Key Engineering Materials
Vol. 351
Vol. 351
Key Engineering Materials
Vol. 350
Vol. 350
Key Engineering Materials
Vols. 348-349
Vols. 348-349
Key Engineering Materials
Vol. 347
Vol. 347
Key Engineering Materials
Vols. 345-346
Vols. 345-346
Key Engineering Materials
Vol. 344
Vol. 344
Key Engineering Materials
Vols. 342-343
Vols. 342-343
Key Engineering Materials
Vols. 340-341
Vols. 340-341
Key Engineering Materials
Vol. 339
Vol. 339
Key Engineering Materials
Vols. 336-338
Vols. 336-338
Key Engineering Materials
Vols. 334-335
Vols. 334-335
Key Engineering Materials
Vol. 333
Vol. 333
Key Engineering Materials
Vols. 330-332
Vols. 330-332
Key Engineering Materials Vols. 342-343
Paper Title Page
Abstract: Methoxy poly(ethylene glycol) (MPEG)-b-poly(ε-caprolactone) (PCL) diblock
copolymer was synthesized by ring-opening of ε-caprolactone (ε-CL) in the presence of a monomer
activator with the terminal alcohol of MPEG as an initiator. The temperature sensitive behavior of
the prepared MPEG-PCL diblock copolymer solution was examined. The polymer solution formed
translucent sol at the room temperature. As the temperature increased from room temperature, the
sol became gel, indicating that the diblock copolymer solution at room temperature can form gel at
body temperature. Brain-derived neurotrophic factor (BDNF) loaded MPEG-PCL diblock
copolymer solution and Pluronic solution for comparison were prepared to examine the release
behavior of BDNF. Pluronic gel exhibited nearly complete release of BDNF even at 2 day, while
the release of BDNF in MPEG-PCL gel showed the prolonged release profile for 21 days. In this
study, we confirmed that thermosensitive MPEG-PCL diblock copolymer in this work could utilize
as a potential carrier of BDNF.
473
Abstract: 5-Fluorouracil-poly(L-lactide) (5-Fu-PLLA) microspheres have been co-precipitated in a
process namely solution-enhanced dispersion by supercritical CO2 (SEDS). First, the 5-Fu is
successfully micronized and then used to produce the 5-Fu-PLLA microspheres. The 5-Fu-PLLA
microspheres synthesized in the SEDS process exhibited a rather spherical shape, smooth surface,
and a narrow particle size distribution, where it ranged from 531 nm to 1280 nm, with a mean
particle size of 793 nm. The dichloromethane residue in the 5-Fu-PLLA microspheres is 46 ppm.
The average drug load of the 5-Fu-PLLA microspheres is 12.7%. The results of this study indicate
that the SEDS process is an effective technique to co-precipitate 5-Fu and PLLA as composite
microspheres.
477
Abstract: Three kinds of curcumin-loaded films (3wt%, 5wt%, 8wt%) were prepared using
poly(lactic acid-co-glycol acid (PLGA) as the carrier of curcumin, and studied. The result of Fourier
transform infrared spectroscopy (FTIR) and X-ray electron spectroscopy (XPS) show that the
curcumin is dispersed in the PLGA films. High performance liquid chromatography (HPLC)
analysis suggests that the release of curcumin can last 22-43 days. A fewer number of adhered and
activated platelets are observed on the curcumin-loaded PLGA films. The activated partial
thromboplastin time (APTT) increases for all curcumin-loaded films.
481
Abstract: To develop osmotic granule with semi-permeable membranes, we prepared the semipermeable
membranes with different pore forming agent by using solvent casting method. The
membrane was consisted of cellulose acetate, Eudragit® RS, hydroxypropylcellulose (HPC), and
triethylcitrate (TEC) in the presence of PEG200, PEG1, 000, or dibutylsebacate(DBS) as a pore
forming agent. The produced membranes were white and elastic and exhibited soft property on
touch. The release amount of pore forming agent from membrane with different pore forming agent
was measured in water dissolution media and the order was PEG200 > PEG1, 000 > DBS. The
formation of pore in membrane was observed by morphological SEM image after dissolution. The
pore formation and porosity of membrane depended on water solubility of pore forming agent. We
confirmed that pores in porous semi-permeable membrane could be controlled by the pore forming
agent.
485
Abstract: The inclusion complex of CO2-soluble peracetylated-β-cyclodextrin (PAc-β-
CD), heptakis(2,3,6-tri-O-acetyl)-β-cyclodextrin, and highly water-soluble drug captopril,
was prepared by a chemical solvent-free method using supercritical carbon dioxide. The
captopril-PAc-β-CD inclusion complex was further confirmed by DSC and XRD studies.
In- vitro release of captopril from an oily suspension confirmed that the dissolution rate of
captopril was much retarded from the inclusion complex as a result of the hydrophobic
properties of PAc-β-CD.
489
Abstract: Hydrophobically modified derivative of a γ-cyclodextrin, functionalized with
perfluoro alkyl ester group, was prepared and investigated for its potential use as a
sustained release carrier for water-soluble drug molsidomine, a peripheral nitrovasodilator
used in the treatment of angina pectoris. The molecular encapsulation of molsidomine by
the amphiphilic cyclodextrin, octakis(6-O-perfluorobutanoyl)-γ-cyclodextrin (γ-CyD-F),
was confirmed by DSC and XRD studies. The in-vitro release of molsidomine from
peanut oil suspensions into aqueous phase was found to be significantly retarded by the
complexation with γ-CyD-F, mainly due to the hydrophobic properties of the γ-CyD-F.
493
Abstract: The rapid prototyping (RP) technology has advanced in various fields such as verification
of design, and functional test. Recently, researchers have studied bio-materials to fabricate
functional bio-RP parts. In this research, a nano composite deposition system (NCDS) was
developed to fabricate three-dimensional functional parts for bio-applications. In the hybrid process,
the material removal process by mechanical micro machining and/or the deposition process are
combined. NCDS uses biocompatible or biodegradable polymer resin as matrix and various bioceramics
to form bio-composite materials. To test drug release rate in vivo environment, two
different types of drug delivery system (DDS) were fabricated using the bio-composite materials. 1)
Container type DDS used poly(DL-lactide-co-glycolide acid)(50:50) and 5-fluorouracil as the drug
composite while polycaprolactone(PCL) served as the container of the drug. 2) Scaffold type DDS
formed porous microstructure with poly(DL-lactide-co-glycolide acid)(50:50) and 5-fluorouracil
composite. The effect of geometry of the DDS on release rate of drug is under investigation.
497
Abstract: Supercritical carbon dioxide (scCO2) was used as a processing medium for the
fabrication of drug encapsulated poly(DL-lactide-co-glycolide) (PLGA) monoliths for
their potential application in the controlled release of water soluble drugs. Exposure of
PLGA to scCO2 leads to effective plasticization and liquefaction due to the high solubility
and interaction of the scCO2 in the copolymer. By exploiting this property, it was
demonstrated that prolonged release formulations of molsidomine, a peripheral
nitrovasodilator used to treat angina pectoris, can be prepared by chemical solvent-free,
scCO2 assisted drug impregnation method. The in-vitro dissolution studies revealed that
the release rates of drug from the porous polymer monoliths containing different amount
of the drug samples were significantly retarded due to encapsulation of molsidomine into
the PLGA matrix.
501
Abstract: Stability and disintegration of natural polyelectrolyte complex microspheres for protein
drugs delivery have been extensively investigated because of their great influence on the drug
release patterns. In this study, we tested stability of microspheres with alginate (Alg) core layered
by either chitosan (Chi) or glycol chitosan (GChi) by examining release profiles of fluorophorelabeled
bovine serum albumin (BSA) and lysozyme (Lys) from the microspheres. While GChi shell
was disintegrated quickly, Chi-shell microspheres showed good stability in PBS. Disintegration of
the coated layer induced the core material instable. The results indicated that while the charges of
the shell material provided additional diffusion barrier against the protein release, the key factor to
hold the proteins inside the microspheres was the integrity of the outer coating layer.
505
Abstract: To improve the specific accumulation in tumor sites and aqueous solubility of atRA, the
core-shell type of folate-PEG-g-PEI/atRA nanoparticles were prepared by complexation between
cationic PEI segments in the copolymers and anionic charged atRA, and then characterized by 1HNMR,
ELS, XRD, and TEM. In vitro atRA release from the nanoparticles was investigated as a
function of drug content in sink condition. Cytotocicity of atRA against HepG2, KB cell lines were
also evaluated by MTT assay. The lower the drug content, the faster atRA release. atRA
incorporated in folate-PEG-g-PEI/atRA nanoparticles showed much higher cytotoxic effect
compared with atRA itself.
509